Despite encouraging biomarker shifts, oral semaglutide failed to slow cognitive decline in early Alzheimer’s, leading to an early end of the trial extension.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/semaglutide-fails-slow-cognitive-decline-early-alzheimers-2025a1000wsz?src=rss
Author :
Publish date : 2025-11-24 19:48:00
Copyright for syndicated content belongs to the linked Source.
